Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton adverse drug reactions risk (BADRI) model

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Tangiisuran, Balamurugan ^a   Scutt, Greg ^b   Stevenson, Jennifer ^b   Wright, Juliet ^c   Onder, G ^d   Petrovic, M ^e   Van Der Cammen, T J ^c,f,g   Rajkumar, Chakravarthi ^c   Davies, Graham ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d CATHOLIC UNIVERSITY   (Italy)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g FACULTY OF INDUSTRIAL DESIGN ENGINEERING   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ADVERSE DRUG REACTION; AGED; AREA UNDER THE CURVE; ARTICLE; BRIGHTON ADVERSE DRUG REACTION RISK MODEL; DRUG USE; FEMALE; HUMAN; HYPERLIPIDEMIA; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; COMORBIDITY; DATA BASE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; HOSPITALIZATION; MULTIVARIATE ANALYSIS; REPRODUCIBILITY; RISK FACTOR; THEORETICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DATABASES AS TOPIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84910031001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111254     Document Type: Article

References (33)

1. United States Census Bureau (2000) Projections of the Total Resident Population by 5-Year Age Groups, and Sex with Special Age Categories: Middle Series, 1999 to 2000. Available: http://www.census.gov/population/projections/files/natproj/summary/np-t3-a.pdf. Accessed 2013 October.
2. United States Census Bureau (2012) Projections of the Population by Selected Age Groups and Sex for the United States: 2015 to 2060. Available: http://www.census.gov/population/projections/data/national/2012/summarytables.html. Accessed 2013 October.
3. Office for National Statistics (2007) National Population Projections, 2006-based projections. Available: http://www.ons.gov. uk/ons/rel/npp/nationalpopulation-projections/2006-based-projections/index.html. Accessed 2013 October.
4. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, et al. (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858-1866.
5. Kannel WB, Cupples LA, D'Agostino RB (1987) Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 113:799-804.
6. McElnay JC, McCallion CR, AlDeagi F, Scott MG (1997) Development of a risk model for adverse drug events in the elderly. Clinical Drug Investigation 13:47-55.
7. Trivalle C, Cartier T, Verny C, Mathieu AM, Davrinche P, et al. (2010) Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging 14:57-61.
8. Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, et al. (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Archives of internal medicine 170:1142-1148.
9. O'Connor MN, Gallagher P, Byrne S, O'Mahony D (2012) Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing 41:771-776.
10. Tangiisuran B, Davies JG, Wright JE, Rajkumar C (2012) Adverse drug reactions in a population of hospitalized very elderly patients. Drugs & Aging 29:669-679.
11. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255-1259.
12. Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA: the journal of the American Medical Association 266:2847-2851.
13. Rozich JD, Haraden CR, Resar RK (2003) Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Quality & safety in health care 12:194-200.
14. Resar RK, Rozich JD, Classen D (2003) Methodology and rationale for the measurement of harm with trigger tools. Qual Saf Health Care 12 Suppl 2:ii39-45.
15. Handler SM, Hanlon JT, Perera S, Roumani YF, Nace DA, et al. (2008) Consensus list of signals to detect potential adverse drug reactions in nursing homes. Journal of the American Geriatrics Society 56:808-815.
16. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, et al. (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228:83-90.
17. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, et al. (2003) Adverse drug events in ambulatory care. N Engl J Med 348:1556-1564.
18. World Health Organization (2004) International statistical classification of diseases and related health problems. Geneva: World Health Organization.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine 130:461-470.
20. Hosmer DW, Lemeshow S (1989) Applied logistic regression: Wiley.
21. Bewick V, Cheek L, Ball J (2004) Statistics review 13: receiver operating characteristic curves. Crit Care 8:508-512.
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245.
23. Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, et al. (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371-377.
24. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, et al. (2000) Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 49:158-167.
25. Mannesse CK, Derkx FH, de Ridder MA, Man in 't Veld AJ, van der Cammen TJ (1997) Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. Bmj 315:1057-1058.
26. Corsonello A, Pedone C, Corica F, Mazzei B, Di Iorio A, et al. (2005) Concealed Renal Failure and Adverse Drug Reactions in Older Patients With Type 2 Diabetes Mellitus. J Gerontol A Biol Sci Med Sci 60:1147-1151.
27. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, et al. (2007) Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 63:136-147.
28. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H (2008) Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug safety: an international journal of medical toxicology and drug experience 31:789-798.
29. Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, et al. (2009) Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 338:a2752.
30. Schneider JK, Mion LC, Frengley JD (1992) Adverse drug reactions in an elderly outpatient population. American journal of hospital pharmacy 49:90-96.
31. Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, et al. (2009) Heart failure and adverse drug reactions among hospitalized older adults. Clinical pharmacology and therapeutics 86:307-310.
32. Zeeh J, Platt D (2002) The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121-127.
33. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, et al. (2006) Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. The journals of gerontology Series A, Biological sciences and medical sciences 61:511-515.